Evidence map›Paper›PMID 39749152›Full record

ArticleMateria socio-medica2024

Type and Significance of Transfunded Blood Products.

Sabina Camdzic-Smajic, Aida Zabic, Svetlana Jovic, Ahida Suljkanovic-Mahmutovic, Sunita Custendil-Delic, Alma Osmic-Husni

Abstract read
In one paragraph

Article in Materia socio-medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabina Camdzic-SmajicPolyclinic for Blood Transfusion, University Clinical Cente Tuzla, Tuzla, Bosnia and Herzegovina.
Aida ZabicPolyclinic for Blood Transfusion, University Clinical Cente Tuzla, Tuzla, Bosnia and Herzegovina.
Svetlana JovicPolyclinic for Blood Transfusion, University Clinical Cente Tuzla, Tuzla, Bosnia and Herzegovina.
Ahida Suljkanovic-MahmutovicPolyclinic for Blood Transfusion, University Clinical Cente Tuzla, Tuzla, Bosnia and Herzegovina.
Sunita Custendil-DelicPolyclinic for Blood Transfusion, University Clinical Cente Tuzla, Tuzla, Bosnia and Herzegovina.
Alma Osmic-HusniPolyclinic for Laboratory diagnostic University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Blood transfusion is when blood and blood products are given to patients during medical treatment. Nowadays, transfusion centers worldwide constantly face the same challenge: how to provide sufficient quantities of high-quality and safe preparations for each patient at the right time. Objective: The aim of the study was to determine the number of transfused patients,the amount and type of blood products in the Polyclinic of Transfusion in the period from 01.01. to 31.12.2021. Methods: The data about the total number of blood donations, the number of blood products produced from whole blood, and the type of blood products issued, were retrospectively used from the available database of the information system Renovation Polyclinic of transfusion, University Clinical Centre Tuzla, Bosnia and Herzegovina. Results: The study was carried out at the University Clinical Center Tuzla in the Polyclinic for Transfusion, in the period 01.01.2021-31.12.2021., where 29672 different blood preparations were given for the transfusion treatment of 5081 patients. In the same period, 14191 voluntary blood donors came to the Polyclinic for Transfusion of the University Clinical Center Tuzla 75.4% donated blood, and 24.6% of donors did not meet the requirements for donating blood. In the investigated period out of a total of 5,081 transfused patients, 27.4% received only one type of blood product, and even 72.6% of patients were transfused with several different blood products. Conclusion: According to our results, we can conclude that the maximum number of collected blood units is transfused, and some plasma preparations are even 86.3% more than collected, which leads us to the conclusion that it is necessary to maintain the continuity of the collection of blood supplies and to work on increasing the number of voluntary blood donors to ensure needed blood products for treatment of patients, and in the same time keep the minimum of blood reserve for extraordinary situation as was COVID-19 pandemic.

Indexed as

blood componentspatientstransfusion

Identifiers

PMID39749152
PMCPMC11693120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.